1) phase Ⅱ clinical trial
Ⅱ期临床实验
2) phase Ⅲ clinical trial
3期临床实验
3) Phase II clinical study
II期临床实验
4) phaseⅠ
Ⅰ期
1.
METHODS:This study was a phaseⅠanti- tumor clinical trial for CIK cells in tumor-bearing patients.
方法:进行CIK细胞抗肿瘤Ⅰ期临床试验,21例恶性肿瘤病人采集外周血单个核细胞诱导CIK细胞,按CIK细胞静脉滴注(静滴)剂量分为4个治疗组观察不良反应,并测定静滴前后病人外周血淋巴细胞活化相关表面标志。
2.
The summary of managing experience through tested ones for phaseⅠclinical drug trials, presented specific characteristics providing as preliminary clinical pharmacologic basis and evaluation test of safety for human beings.
对开展药物Ⅰ期临床试验的受试者的管理进行经验总结,认为Ⅰ期临床试验是初步的临床药理学及人体安全性评价试验,具有特殊性。
5) phase Ⅱ
Ⅱ期
1.
Effects of domperidone maleate on 63 patients with functional dyspepsia: a multicenter, double-blind, double-dummy phase Ⅱ clinical trial;
马来酸多潘立酮治疗功能性消化不良63例的Ⅱ期临床试验
2.
Effect of Liqifuwei oral liquid in treatment for functional dyspepsia, a phase Ⅱ clinical trial;
理气复胃口服液治疗功能性消化不良Ⅱ期临床试验
6) stage Ⅲa
Ⅲa期
1.
The application of neoadjuvant chemotherapy in patients with stage Ⅲa non-small cell lung cancer;
新辅助化疗在Ⅲa期非小细胞肺癌治疗中的应用
2.
Application of Neoadjuvant Chemotherapy in Patients With NSCLC in Stage Ⅲa;
新辅助化疗在Ⅲa期肺癌治疗中的应用
参考词条
补充资料：与期
1.预先期待。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。